Alithea Genomics Blog

Search area of interest

16 Mar 2026

How High-Throughput Transcriptomics Solves the AI Training Data Bottleneck in Drug Discovery

Next-generation AI models for drug discovery are only as powerful as the quality, size, and perturba...

Written by Daniela Cabuzu

Drug Discovery
DRUG-seq
High-throughput screening
AI-trainig

16 Mar 2026

SOT Annual Meeting and ToxExpo 2026: Key Themes in Omics-Driven Mechanistic Toxicology to Watch

As the SOT Annual Meeting and ToxExpo 2026 approaches, we take a pre-conference look at the programm...

Written by Daniela Cabuzu

Drug Discovery
DRUG-seq
Cell Painting
Toxicology
SOT2026

24 Feb 2026

What is DRUG-seq, and What Are Its Benefits in Drug Discovery?

DRUG-seq is a cost-effective, high-throughput bulk RNA-seq library preparation method for compound s...

Written by Daniela Cabuzu

Drug Discovery
DRUG-seq

21 Dec 2025

Case Study: Combining High-Content Imaging and MERCURIUS™ DRUG-seq to Identify Brain-Penetrant Modulators of Microglial Function

Identifying brain-penetrant small-molecule modulators of human microglia using a cellular model of s...

Written by Daniela Cabuzu

DRUG-seq
Case study

18 Dec 2025

Published DRUG-seq vs MERCURIUS™ DRUG-seq: Key Differences Explained

DRUG-seq, first published in 2018, has transformed how pharmaceutical, cosmetics, agritech, and AI d...

Written by Daniela Cabuzu

DRUG-seq

09 May 2025

Overview of Published 3’ mRNA-seq Workflows: From Early Multiplexing and Beyond

Written by Daniela Cabuzu

BRB-seq
DRUG-seq

02 May 2025

Published Bulk 3’ mRNA-seq Technologies: Which is Best for Your Next Screen?

3’ mRNA-seq technologies are gradually revolutionizing high-throughput bulk transcriptomics.

Written by Daniela Cabuzu

BRB-seq
DRUG-seq
3' mRNA-seq

15 Apr 2025

TempO-seq™ for High-Throughput Toxicology: A Case Study

As a researcher performing large-scale drug-discovery, genetic perturbation, or toxicogenomic screen...

Written by Daniela Cabuzu

Drug Discovery
TempO-Seq
DRUG-seq

04 Apr 2025

How can pairing the JUMP-Cell Painting Gallery with MERCURIUS™ DRUG-seq help your large-scale drug discovery or toxicology study?

For researchers in pharma, biotech, or academia looking to uncover the mechanisms of action, cytotox...

Written by Daniela Cabuzu

Drug Discovery
DRUG-seq
Cell Painting
JUMP-CP

02 Apr 2025

What is JUMP-CP consortium?

The Joint Undertaking in Morphological Profiling-Cell Painting Gallery (JUMP-CP) is a large-scale, h...

Written by Daniela Cabuzu

Drug Discovery
DRUG-seq
Cell Painting
JUMP-CP

26 Mar 2025

Missed Toxicity Signals? Unclear Mechanisms of Action? Can MERCURIUS™ DRUG-seq and Cell Painting De-Risk Drug Discovery?

For researchers performing drug discovery, drug repurposing, toxicogenomic screens, or CRISPR screen...

Written by Daniela Cabuzu

Drug Discovery
DRUG-seq
Cell Painting

18 Mar 2025

Can Combining Cell Painting and L1000 Accelerate Drug Discovery?

Large-scale perturbational profiling is time and cost-intensive, so it’s crucial to compare the capa...

Written by Daniela Cabuzu

L1000
DRUG-seq
Cell Painting

1 2

Blog & tutorials

How High-Throughput Transcriptomics Solves the AI Training Data Bottleneck in Drug Discovery

SOT Annual Meeting and ToxExpo 2026: Key Themes in Omics-Driven Mechanistic Toxicology to Watch

What is DRUG-seq, and What Are Its Benefits in Drug Discovery?

Case Study: Combining High-Content Imaging and MERCURIUS™ DRUG-seq to Identify Brain-Penetrant Modulators of Microglial Function

Published DRUG-seq vs MERCURIUS™ DRUG-seq: Key Differences Explained

Overview of Published 3’ mRNA-seq Workflows: From Early Multiplexing and Beyond

Published Bulk 3’ mRNA-seq Technologies: Which is Best for Your Next Screen?

TempO-seq™ for High-Throughput Toxicology: A Case Study

How can pairing the JUMP-Cell Painting Gallery with MERCURIUS™ DRUG-seq help your large-scale drug discovery or toxicology study?

What is JUMP-CP consortium?

Missed Toxicity Signals? Unclear Mechanisms of Action? Can MERCURIUS™ DRUG-seq and Cell Painting De-Risk Drug Discovery?

Can Combining Cell Painting and L1000 Accelerate Drug Discovery?

Subscribe to our newsletter